UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL — Stella

Recruiting

Back to B-cell Acute Lymphoblastic Leukemia trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Children's Hospital Colorado, Aurora, Colorado

Key details

Phase

Early testing / Safety & dosing

Sponsor

University of Colorado, Denver

Collaborators

Children's Hospital Colorado

Enrollment target

~45 participants

Started

March 2021

Primary completion

June 2026

Age range

31 Days – 30 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov